BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8668765)

  • 1. Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?
    Pharoah PD; Watson JM; Sen S
    Public Health; 1996 May; 110(3):179-83. PubMed ID: 8668765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
    Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
    Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
    Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
    Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates.
    Joseph CA; Watson JM; Fern KJ
    BMJ; 1992 Aug; 305(6852):495-8. PubMed ID: 1392994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective neonatal BCG vaccination.
    Bakshi D; Sharief N
    Acta Paediatr; 2004 Sep; 93(9):1207-9. PubMed ID: 15384885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of neonatal BCG immunization within an acute hospital trust.
    Eastham KM; Wyllie J
    J Public Health Med; 2001 Dec; 23(4):335-8. PubMed ID: 11873898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: a questionnaire study.
    Gordon M; Roberts H; Odeka E
    BMC Infect Dis; 2007 Jul; 7():82. PubMed ID: 17650337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
    Kobayashi S; Yoshiyama T; Uchimura K; Hamaguchi Y; Kato S
    Sci Rep; 2021 Aug; 11(1):15902. PubMed ID: 34354146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European survey of BCG vaccination policies and surveillance in children, 2005.
    Infuso A; Falzon D;
    Euro Surveill; 2006; 11(3):6-11. PubMed ID: 16567882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of neonatal BCG vaccines against tuberculous meningitis.
    Puvacić S; Dizdarević J; Santić Z; Mulaomerović M
    Bosn J Basic Med Sci; 2004 Feb; 4(1):46-9. PubMed ID: 15628980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does BCG have a role in tuberculosis control and prevention in the United Kingdom?
    Teo SS; Shingadia DV
    Arch Dis Child; 2006 Jun; 91(6):529-31. PubMed ID: 16714729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the selective neonatal BCG program.
    Wroe AL; McKeever C; Thackray S; Bhan A
    Public Health Nurs; 2007; 24(1):60-5. PubMed ID: 17214654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacillus Calmette-Guérin (BCG) vaccine coverage in newborns and infants at risk before and after a change in BCG policy].
    Parache C; Carcopino X; Gossot S; Retornaz K; Uters M; Mancini J; Garnier JM; Minodier P
    Arch Pediatr; 2010 Apr; 17(4):359-65. PubMed ID: 20219333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking changes in national BCG vaccination policies and practices using the BCG World Atlas.
    Lancione S; Alvarez JV; Alsdurf H; Pai M; Zwerling AA
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 35039309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.